We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients?
AI summary Read the abstract
Researchers measured microplastics in the blood of 114 patients before and after 174 therapeutic plasma exchange procedures. Circulating microplastic levels were lower afterward. At low starting levels the drop was obscured, because the plastic tubing of the device shed particles back into the blood.
Microplastic particles (MP) from industrial products and degradation of plastic waste are ubiquitous in our environment and convey serious potential risks to human health. There is currently no established method for removing MP from the human body. MP circulate in the blood and have been found in the eluate plasma from double filtration plasmapheresis procedures, suggesting that plasmapheresis could be used to remove MP from the body. We have measured circulating MP in the blood of 114 patients before and after 174 1-plasma-volume therapeutic plasma exchange (TPE) procedures using the Spectra Optia Apheresis System and have shown that circulating MP are reduced by TPE. The reduction is obscured at low starting levels of MP because of leaching of MP back into the circulation from the plastic apheresis tubing set. Nonetheless, this is the first demonstration that it is possible to reduce circulating MP in human patients.
More Papers Like This
Microplastic entry into bloodstream via hemodialysis: A dual-simulation clinical study
AI summary Read the abstract
Researchers measured microplastics in the blood of nine patients before and after hemodialysis, finding that particle counts nearly doubled post-procedure, with polymer types matching dialysis tubing materials — suggesting medical plastic devices are a direct route of microplastic entry into the bloodstream.
Therapeutic apheresis: A promising method to remove microplastics?
AI summary Read the abstract
A short report proposing that therapeutic apheresis, an established procedure that filters blood through an external device, could lower micro- and nanoplastic levels in human blood. The authors present first evidence and describe the method as having potential.
Therapeutic apheresis: A promising method to remove microplastics?
AI summary Read the abstract
Researchers report first evidence that therapeutic apheresis, a procedure that runs blood through an external filter, may lower the amount of micro- and nanoplastics in human blood. The abstract gives no figures, and the authors describe the method as having potential.
Microplastics and Nanoplastics in Human Blood: What the Latest Research Shows
AI summary Read the abstract
A review of recent evidence that micro- and nanoplastics circulate in human blood, drawing on several detection methods. It covers associations with artery plaque and coagulation and examines plasma exchange and blood donation as research questions. Causation remains an open question.
Percutaneous coronary intervention leads to microplastics entering the blood: Interventional devices are a major source
AI summary Read the abstract
Researchers measured microplastic levels in the blood of 23 patients before and after heart stent procedures (percutaneous coronary intervention) and found that microplastic concentrations jumped nearly 19-fold after the procedure. The types of plastics found in the blood matched those detected on the medical devices used during the procedure, confirming that the devices themselves were the source. This study reveals that common medical procedures using plastic equipment may be an overlooked route for microplastics to enter the human bloodstream.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.